Zofia Piotrowska, MD, MHS | Authors


Examining the Impact of the FLAURA Trial in EGFR-Mutant NSCLC

March 14, 2020

Zofia Piotrowska, MD, MHS, discusses the rationale for conducting the FLAURA trial in patients with EGFR-mutant non–small cell lung cancer and how the use of osimertinib impacted the treatment landscape for this patient population.